Principal Engineer, Software - Image Analysis at Eikon Therapeutics

Millbrae, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, BiotechnologyIndustries

Requirements

Bachelor's degree with 15 years of relevant experience or a master's degree with 12 years of relevant experience or a PhD with 8 years of relevant experience in Computer Science, Software Engineering or a related field
Strong proficiency in React, TypeScript, Postgres and Python
Experience in multiple strongly typed languages such as C++, C# or Java
Successful track record designing software and systems architecture, including API and database design, commercial application development, cloud services, and DevOps practices
Experience with architecting and building analysis software in the biotech field
Excellent verbal and written communication skills, ability to bridge the gap between scientific users and engineers and developers
Team-oriented, flexible, able to adapt to rapidly evolving goals and challenges
Demonstrated leadership skills in a changing organization with evolving processes

Responsibilities

Build a reliable and scalable software pipeline to extract features from Eikon’s proprietary microscopy data
Maintain essential computational pipelines for ongoing scientific research
Define and evolve the engineering system architecture vision to support system features and user-facing capabilities
Lead a small team as technical lead or direct manager
Characterize and communicate design trade-offs to technical and non-technical audiences
Collaborate with Product and Program Management to develop high-level roadmaps for key software deliverables satisfying defined system-level business needs and user acceptance tests
Stay up to date with emerging trends and advancements in machine learning, distributed systems, cloud technologies, and software engineering practices, and evaluate their potential impact on our internal products

Skills

Software Engineering

Computational Pipelines

Image Analysis

Machine Learning

Distributed Systems

Cloud Technologies

System Architecture

Data Processing

High-Throughput Data

Team Leadership

Eikon Therapeutics

Biotech startup developing innovative medicines

About Eikon Therapeutics

Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that aim to improve and extend life. A key feature of Eikon's approach is their proprietary single-molecule tracking (SMT) platform, which enables rapid visualization of protein movements in living cells. This technology, along with artificial intelligence and automation, allows for precise inventorying of molecular interactions. Eikon Therapeutics targets patients with serious diseases who need effective treatments, generating revenue through the development and commercialization of their therapies.

Hayward, CaliforniaHeadquarters

2019Year Founded

$750.8MTotal Funding

SERIES_CCompany Stage

AI & Machine Learning, BiotechnologyIndustries

201-500Employees

Benefits

401(k) Company Match

Medical (premiums covered by Eikon at 95%)

Dental Insurance

Vision Insurance

Mental Health Support

Unlimited Paid Time Off

Paid Holidays

Life Insurance

Enhanced Parental Leave

Daily subsidized lunch program

Risks

Competition from biotech unicorns like Abogen Biosciences is increasing.

Integrating new clinical-stage assets may delay drug development timelines.

Reliance on SMT technology risks obsolescence from emerging molecular biology technologies.

Differentiation

Eikon uses proprietary single-molecule tracking for real-time protein movement analysis.

The company integrates AI and automation for large-scale molecular interaction studies.

Eikon's diverse team combines expertise in science, engineering, and technology.

Upsides

Growing interest in SMT technology boosts Eikon's drug discovery potential.

Partnerships with AI firms enhance Eikon's drug candidate identification.

Rising demand for precision medicine aligns with Eikon's focus on dynamic biology.

Land your dream remote job 3x faster with AI

Try Jobo Free